Retinoid X receptor modulators
US7348359B2 · kind B2 · utility
11Cited by
1References
37Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 14, 2002 |
| Grant date | Mar 25, 2008 |
| Priority date | — |
| Expiry date | Mar 2, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof: (I). The invention is also directed to pharmaceutical compositions, methods of use and methods of making compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.